VANGUARD GROUP INC - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 226 filers reported holding EDITAS MEDICINE INC in Q1 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q3 2023$66,582,423
-0.9%
8,536,208
+4.5%
0.00%0.0%
Q2 2023$67,201,851
+28.7%
8,165,474
+13.4%
0.00%
+100.0%
Q1 2023$52,219,677
-14.3%
7,202,714
+4.8%
0.00%
-50.0%
Q4 2022$60,964,601
-25.9%
6,873,123
+2.2%
0.00%0.0%
Q3 2022$82,318,000
+4.9%
6,725,340
+1.4%
0.00%0.0%
Q2 2022$78,499,000
-40.0%
6,635,610
-3.5%
0.00%
-33.3%
Q1 2022$130,792,000
-26.2%
6,876,539
+3.0%
0.00%
-25.0%
Q4 2021$177,192,000
-33.1%
6,673,897
+3.6%
0.00%
-42.9%
Q3 2021$264,685,000
-27.9%
6,443,150
-0.6%
0.01%
-22.2%
Q2 2021$367,250,000
+37.8%
6,483,932
+2.1%
0.01%
+28.6%
Q1 2021$266,606,000
-34.7%
6,347,754
+9.0%
0.01%
-41.7%
Q4 2020$408,383,000
+155.0%
5,824,886
+2.0%
0.01%
+140.0%
Q3 2020$160,168,000
-6.0%
5,708,036
-0.9%
0.01%
-16.7%
Q2 2020$170,395,000
+82.4%
5,760,473
+22.3%
0.01%
+50.0%
Q1 2020$93,439,000
-30.9%
4,712,033
+3.2%
0.00%
-20.0%
Q4 2019$135,247,000
+37.7%
4,567,616
+5.8%
0.01%
+25.0%
Q3 2019$98,209,000
-7.5%
4,318,765
+0.7%
0.00%0.0%
Q2 2019$106,156,000
+10.3%
4,290,861
+9.0%
0.00%0.0%
Q1 2019$96,225,000
+9.5%
3,935,605
+1.9%
0.00%0.0%
Q4 2018$87,860,000
-26.0%
3,862,012
+3.6%
0.00%
-20.0%
Q3 2018$118,675,000
-7.7%
3,729,579
+3.9%
0.01%0.0%
Q2 2018$128,557,000
+28.6%
3,587,970
+19.0%
0.01%
+25.0%
Q1 2018$99,984,000
+17.5%
3,016,108
+8.9%
0.00%0.0%
Q4 2017$85,074,000
+54.3%
2,768,403
+20.5%
0.00%
+33.3%
Q3 2017$55,146,000
+50.9%
2,296,755
+5.5%
0.00%
+50.0%
Q2 2017$36,533,000
-15.4%
2,177,146
+12.5%
0.00%0.0%
Q1 2017$43,193,000
+102.2%
1,935,173
+47.0%
0.00%
+100.0%
Q4 2016$21,365,000
+26.8%
1,316,384
+5.3%
0.00%0.0%
Q3 2016$16,844,000
+29.5%
1,249,559
+134.5%
0.00%0.0%
Q2 2016$13,004,000
-49.8%
532,969
-29.0%
0.00%
-50.0%
Q1 2016$25,915,000750,2920.00%
Other shareholders
EDITAS MEDICINE INC shareholders Q1 2023
NameSharesValueWeighting ↓
NIA IMPACT ADVISORS, LLC 54,615$4,897,0002.55%
Capital Impact Advisors, LLC 130,000$9,114,0002.24%
ARK Investment Management 10,125,564$709,903,0001.89%
Nikko Asset Management Americas, Inc. 4,388,143$307,653,0001.75%
Spectrum Planning & Advisory Services Inc. 17,522$1,228,0001.32%
DDD Partners, LLC 79,527$5,576,0001.10%
Brevan Howard Capital Management LP 76,420$5,358,0001.08%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 538,721$37,770,0000.75%
DC Investments Management, LLC 3,627$254,0000.63%
Haafor (Singapore) Pte. Ltd. 4,761$334,0000.62%
View complete list of EDITAS MEDICINE INC shareholders